Cerebrovascular Accidents in Ranibizumab
- 28 February 2009
- journal article
- other
- Published by Elsevier in Ophthalmology
- Vol. 116 (2) , 362-362.e1
- https://doi.org/10.1016/j.ophtha.2008.09.046
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 ResultsPublished by Elsevier ,2008
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1American Journal of Ophthalmology, 2008
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006